Pamiparib Pamiparib
Formulation and Specifications: Capsules: 20 mgIndications: Pamiparib is indicated for the treatment of patients with recurrent advanced ovarian, fallopian tube, or primary peritoneal cancer with germline BRCA mutations who have…
Formulation and Specifications: Capsules: 20 mgIndications: Pamiparib is indicated for the treatment of patients with recurrent advanced ovarian, fallopian tube, or primary peritoneal cancer with germline BRCA mutations who have…
Formulation and specifications: Capsules: 50mgIndications:1. Maintenance therapy for adult patients with platinum-sensitive recurrent epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer after achieving complete remission or partial remission…
Formulation and Specifications: Capsules: 100mgIndications:1. This product is indicated for the maintenance treatment of adult patients with advanced epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer after achieving…
Formulation and specifications: Tablets: 100mg, 150mgIndications:1. Maintenance therapy for adult patients carrying germline or somatic BRCA mutations in advanced epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer in…